SciBase Entered into an Agreement with Johnson & Johnson to Develop AI-Based Solution for the Detection of Skin Barrier Dysfunction
Shots:
- The collaboration has been initiated and lasted for two years to develop a unique AI-based screening tool for the detection of skin barrier dysfunction & an infant’s risk of developing atopic dermatitis
- The technique will be designed specifically for the mobile Nevisense Go device and will be based on SciBase’s Electrical Impedance Spectroscopy (EIS) technology
- The collaboration will support a study at various hospitals in Switzerland. On successfully completing this test, SciBase expected to have a bigger consumer base because of easy testing and unique predictive data algorithm
Ref: SciBase | Image: SciBase
Click here to read the full press release
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
